Relationship between SGRQ score and pulmonary function and its influencing factors in patients with chronic obstructive pulmonary disease

National Medical Journal of China

Volumn 91, Issue 22, 2011, Pages 1533-1537

  Liu, Rong ^a   Du, Yi Peng ^a   He, Bei ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Age; Pulmonary disease, chronic obstructive; Pulmonary functions; St. George Questionnaire

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL; IPRATROPIUM BROMIDE PLUS SALBUTAMOL;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORRELATIONAL STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FOLLOW UP; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; QUESTIONNAIRE; SAINT GEORGE RESPIRATORY QUESTIONNAIRE; SLOW VITAL CAPACITY; ADULT; FEMALE; LUNG; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME; VITAL CAPACITY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84870474797     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2011.22.007     Document Type: Article

References (15)

1. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med, 1991, 85 Suppl B: 25-31, 33-37.
2. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2002, 166: 680-685.
3. Gudmundsson G, Gislason T, Janson C, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J, 2005, 26: 414-419.
4. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 2007, 176: 532-555.
5. Stahl E, Lindberg A, Jansson SA, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes, 2005, 3: 56.
6. Antonelli-Incalzi R, Imperiale C, Bellia V, et al. Do GOLD stages of COPD severity really correspond to differences in health status? Eur Respir J, 2003, 22: 444-449.
7. Xu W, Collet JP, Shapiro S, et al. Validation and clinical interpretation of the St George's Respiratory Questionnaire among COPD patients, China. Int J Tuberc Lung Dis, 2009, 13: 181-189.
8. 2003, 26: 195-198.
9. El Rhazi K, Nejjari C, Serhier Z, et al. Cross-cultural adaptation difficulties in health quality of life scales for developing countries: example of St-George respiratory questionnaire validation in Morocco. Rev Epidemiol Sante Publique, 2009, 57: 179-189.
10. de Torres JP, Casanova C, Hernandez C, et al. Gender and COPD in patients attending a pulmonary clinic. Chest, 2005, 128: 2012-2016.
11. Jenkins CR, Jones PW, Calverley PM, et al. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res, 2009, 10: 59.
12. Zheng JP, Yang L, Wu YM, et al. The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD. Chest, 2007, 132: 1756-1763.
13. Vercoulen JH, Daudey L, Molema J, et al. An Integral assessment framework of health status in chronic obstructive pulmonary disease (COPD). Int J Behav Med, 2008, 15: 263-279.
14. Daudey L, Peters JB, Molema J, et al. Health status in COPD cannot be measured by the St George's Respiratory Questionnaire alone: an evaluation of the underlying concepts of this questionnaire. Respir Res, 2010, 11: 98.
15. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J, 2009, 34: 648-654.